Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Lilly Gains, Compass Pathways Rises, Fermi Sinks After CEO, CFO Step Down | Stock Movers
Posted
April 20, 2026
Views
237
Likes
3
Engagement
1.27%
April 20, 2026
237
3
1.27%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
3:29Now PlayingOn this episode of Stock Movers:
- Eli Lilly (LLY) shares sunk after the company agreed to buy Kelonia Therapeutics for as much as $7 billion, gaining access to a potential cutting-edge treatment for blood cancer.
- Compass Pathways (CMPS) shares higher after CBS reports that President Trump is set to sign an order as soon as this week that would signal willingness to further research the psychedelic drug ibogaine.
- Fermi (FRMI) shares plunge after after the power company said its chief executive officer and chief financial officers have stepped down as the firm tries to secure its first customer.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Lilly Gains, Compass Pathways Rises, Fermi Sinks After CEO, CFO Step Down
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
